Alexion Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report

Alexion Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Alexion Pharmaceuticals Inc (Alexion) focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the treatment of severe disease states, including genetic diseases, hematologic diseases, cancer, neurological and autoimmune disorders. The company’s marketed product portfolio includes Ultomiris for the treatment of paroxysmal nocturnal hemoglobinuria (PNH); Soliris (eculizumab) used for two indications paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (AHUS); Strensiq (asfotase alfa) for the treatment of hypophosphatasia (HPP) and Kanuma (sebelipase alfa) for the treatment of Lysosomal Acid Lipase Deficiency (LAL Deficiency or LAL-D). Alexion is headquartered in New Haven, Connecticut, the US.

Scope

Detailed information on Alexion Pharmaceuticals Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Alexion Pharmaceuticals Inc in the form of a SWOT analysis

An in-depth view of the business model of Alexion Pharmaceuticals Inc including a breakdown and examination of key business segments

News about Alexion Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Alexion Pharmaceuticals Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Alexion Pharmaceuticals Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Alexion Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Omeros Corp

Ligand Pharmaceuticals Inc

Genzyme Corp

Dart NeuroScience LLC

Baxter International Inc

Amgen Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Alexion Pharmaceuticals Inc - Key Facts

Alexion Pharmaceuticals Inc - Key Employees

Alexion Pharmaceuticals Inc - Key Employee Biographies

Alexion Pharmaceuticals Inc - Major Products and Services

Alexion Pharmaceuticals Inc - History

Alexion Pharmaceuticals Inc - Company Statement

Alexion Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Alexion Pharmaceuticals Inc - Business Description

Product Category: Kanuma

Overview

Performance

Product Category: Soliris

Overview

Performance

Product Category: Strensiq

Overview

Performance

Product Category: Ultomiris

Overview

Geographical Segment: Asia Pacific

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Rest of the world

Performance

Geographical Segment: United States

Performance

R&D Overview

Alexion Pharmaceuticals Inc - Corporate Strategy

Alexion Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Alexion Pharmaceuticals Inc - Strengths

Alexion Pharmaceuticals Inc - Weaknesses

Alexion Pharmaceuticals Inc - Opportunities

Alexion Pharmaceuticals Inc - Threats

Alexion Pharmaceuticals Inc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Alexion Pharmaceuticals Inc, Recent Deals Summary

Section 5 Company’s Recent Developments

Apr 25, 2019: Alexion reports first quarter 2019 results

Apr 08, 2019: Jazz, Alexion and Lundbeck to pay $122m to settle kickback probe

Feb 13, 2019: Drugs targeting metastatic cancers, opioid addiction are among additional specialty drugs available through AllianceRx Walgreens Prime

Feb 12, 2019: Alexion announces creation of new roles on executive leadership team

Feb 11, 2019: Samsung Bioepis forms new alliance to expand in China

Feb 04, 2019: Alexion reports fourth quarter and full year 2018 results

Oct 24, 2018: Alexion reports third quarter 2018 results

Sep 27, 2018: Alexion to buy Syntimmune for up to $1.2bn

Jul 26, 2018: Alexion Reports Second Quarter 2018 Results

Apr 26, 2018: Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Alexion Pharmaceuticals Inc, Key Facts

Alexion Pharmaceuticals Inc, Key Employees

Alexion Pharmaceuticals Inc, Key Employee Biographies

Alexion Pharmaceuticals Inc, Major Products and Services

Alexion Pharmaceuticals Inc, History

Alexion Pharmaceuticals Inc, Subsidiaries

Alexion Pharmaceuticals Inc, Key Competitors

Alexion Pharmaceuticals Inc, Ratios based on current share price

Alexion Pharmaceuticals Inc, Annual Ratios

Alexion Pharmaceuticals Inc, Annual Ratios (Cont…1)

Alexion Pharmaceuticals Inc, Annual Ratios (Cont…2)

Alexion Pharmaceuticals Inc, Interim Ratios

Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Alexion Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Alexion Pharmaceuticals Inc, Performance Chart (2014 – 2018)

Alexion Pharmaceuticals Inc, Ratio Charts

Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Alexion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports